Encouraging Stem Cell Research Published

February 2, 2009 at 11:00 am Leave a comment

Researchers in America have reported encouraging results from a trial treating people with MS with stem cells derived from their bone marrow.

The study, reported in the Lancet Neurology, involved 21 people with relapsing/remitting MS who had had two relapses in the previous year despite treatment with beta interferon. The injections of stem cells followed courses of treatment with immune suppressing drugs.

Following treatment, the participants were followed for an average of three years. All 21 showed no worsening of disability as measured by the EDSS scale, and 17 improved by at least one point. 16 people experienced no further relapses following the stem cell treatment.

The researchers reported that this treatment is ‘a feasible procedure that not only seems to prevent neurological progression, but also appears to reverse neurological disability’. They drew attention to the need for larger, randomised trials.

Pam Macfarlane, Chief Executive of the MS Trust said, “These results are very encouraging and show the potential of stem cells as a treatment for MS. This is a small study and we look forward to larger trials with more people.”


“Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.”

The Lancet Neurology, 30 January 2009 [epub]

MS Trust

[Via http://www.medicalnewstoday.com]

Entry filed under: Uncategorized.

Technical Team’s Response To HHS HIV/AIDS Bureau Announcement Drugs Of Little Use In Treating Dementia

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Top Clicks

  • None

Blog Stats

  • 15,657 hits

%d bloggers like this: